InspireMD, Inc. NSPR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.92% | -22.60% | -28.20% | -61.06% | -66.28% |
| Total Depreciation and Amortization | 47.66% | 52.04% | 90.67% | 82.86% | 62.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.44% | -19.82% | 8.94% | 69.25% | 38.30% |
| Change in Net Operating Assets | -19.74% | -95.37% | -76.19% | 1,725.00% | 26.63% |
| Cash from Operations | -30.75% | -40.32% | -38.44% | -51.46% | -91.39% |
| Capital Expenditure | 42.71% | 45.96% | -27.97% | 21.85% | -21.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 154.04% | 626.49% | -623.06% | 242.92% | -1.39% |
| Cash from Investing | 175.33% | 768.33% | -647.62% | 227.46% | -3.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -88.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 4,035.00% | -312,500.00% | -- |
| Cash from Financing | -- | -- | -100.00% | 5,584.56% | -88.03% |
| Foreign Exchange rate Adjustments | -- | -137.25% | -62.79% | 127.27% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 533.30% | 137.09% | -1,858.04% | 512.94% | -104.60% |